Letter: Drug pricing program needs federal reforms if it is to continue helping patients

Unfortunately, data show the 340B program has lost its way. Taxpayers are footing part of the bill but not seeing any benefits in terms of improved access to affordable medicines.

Related Keywords

United States ,Americans , ,Grand Forks Herald ,New England Journal ,340b Drug Pricing Program ,Medpac ,Medicaid ,Pharmaceutical Research And Manufacturers Of America ,